Literature DB >> 15537658

A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3.

Martin Hülsmeyer1, Patrick Chames, Roman C Hillig, Robyn L Stanfield, Gerhard Held, Pierre G Coulie, Claudia Alings, Gabriele Wille, Wolfram Saenger, Barbara Uchanska-Ziegler, Hennie R Hoogenboom, Andreas Ziegler.   

Abstract

Antibodies with T cell receptor-like specificity possess a considerable diagnostic and therapeutic potential, but the structural basis of the interaction between an antibody and an histocompatibility antigen has so far not been determined. We present here the crystal structure (at 2.15 A resolution) of the recombinant, affinity-matured human antibody fragment Fab-Hyb3 bound to the tumor-associated human leukocyte antigen (HLA)/peptide complex HLA-A1.MAGE-A1. Fab-Hyb3 employs a diagonal docking mode resembling that of T cell receptors. However, other than these natural ligands, the antibody uses only four of its six complementarity-determining regions for direct interactions with the target. It recognizes the C-terminal half of the MAGE-A1 peptide, the HLA-A1 alpha1-helix, and N-terminal residues of the alpha2-helix, accompanied by a large tilting angle between the two types of molecules within the complex. Interestingly, only a single hydrogen bond between a peptide side chain and Fab-Hyb3 contributes to the interaction, but large buried surface areas with pronounced shape complementarity assure high affinity and specificity for MAGE-A1. The HLA-A1.MAGE-A1.antibody structure is discussed in comparison with those of natural ligands recognizing HLA.peptide complexes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15537658     DOI: 10.1074/jbc.M411323200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens.

Authors:  J M Boulter; B K Jakobsen
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

2.  A structurally based approach to determine HLA compatibility at the humoral immune level.

Authors:  Rene J Duquesnoy
Journal:  Hum Immunol       Date:  2006-09-01       Impact factor: 2.850

3.  Loss of recognition by cross-reactive T cells and its relation to a C-terminus-induced conformational reorientation of an HLA-B*2705-bound peptide.

Authors:  Bernhard Loll; Christine Rückert; Chee Seng Hee; Wolfram Saenger; Barbara Uchanska-Ziegler; Andreas Ziegler
Journal:  Protein Sci       Date:  2010-12-23       Impact factor: 6.725

4.  Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7.

Authors:  Arnold H Bakker; Rieuwert Hoppes; Carsten Linnemann; Mireille Toebes; Boris Rodenko; Celia R Berkers; Sine Reker Hadrup; Wim J E van Esch; Mirjam H M Heemskerk; Huib Ovaa; Ton N M Schumacher
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

5.  Structural analysis of human and macaque mAbs 2909 and 2.5B: implications for the configuration of the quaternary neutralizing epitope of HIV-1 gp120.

Authors:  Brett Spurrier; Jared M Sampson; Maxim Totrov; Huiguang Li; Timothy O'Neal; Constance Williams; James Robinson; Miroslaw K Gorny; Susan Zolla-Pazner; Xiang-Peng Kong
Journal:  Structure       Date:  2011-05-11       Impact factor: 5.006

Review 6.  T cell receptor bias for MHC: co-evolution or co-receptors?

Authors:  Sneha Rangarajan; Roy A Mariuzza
Journal:  Cell Mol Life Sci       Date:  2014-03-17       Impact factor: 9.261

7.  Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA.

Authors:  Christopher J Holland; Rory M Crean; Johanne M Pentier; Ben de Wet; Angharad Lloyd; Velupillai Srikannathasan; Nikolai Lissin; Katy A Lloyd; Thomas H Blicher; Paul J Conroy; Miriam Hock; Robert J Pengelly; Thomas E Spinner; Brian Cameron; Elizabeth A Potter; Anitha Jeyanthan; Peter E Molloy; Malkit Sami; Milos Aleksic; Nathaniel Liddy; Ross A Robinson; Stephen Harper; Marco Lepore; Chris R Pudney; Marc W van der Kamp; Pierre J Rizkallah; Bent K Jakobsen; Annelise Vuidepot; David K Cole
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

8.  Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics.

Authors:  Niloufar Ataie; Jingyi Xiang; Neal Cheng; Elliott J Brea; Wenjie Lu; David A Scheinberg; Cheng Liu; Ho Leung Ng
Journal:  J Mol Biol       Date:  2015-12-11       Impact factor: 5.469

9.  Conformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity.

Authors:  Pravin Kumar; Ardeschir Vahedi-Faridi; Wolfram Saenger; Andreas Ziegler; Barbara Uchanska-Ziegler
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

10.  How a T cell receptor-like antibody recognizes major histocompatibility complex-bound peptide.

Authors:  Tatiana Mareeva; Erik Martinez-Hackert; Yuri Sykulev
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.